Marker Therapeutics (MRKR) Shares Issued (2011 - 2025)
Marker Therapeutics (MRKR) reported Shares Issued of $9.9 million for Q4 2025, down 33.67% year-over-year from $14.9 million in Q4 2024, and up 9863178.0% quarter-over-quarter from $100.0 in Q2 2025.
Marker Therapeutics (MRKR) Shares Issued (2011 - 2025) Analysis & Trends
Marker Therapeutics (MRKR) has 15 years of Shares Issued data on file, last reported at $9.9 million in Q4 2025.
- Shares Issued for Q4 2025 came in at $9.9 million, down 33.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.9 million (down 34.07% YoY), and the FY2025 annual result was $9.9 million, down 33.93% from the prior year.
- Shares Issued rose to $9.9 million in Q4 2025 per MRKR's latest filing, from $100.0 in the prior quarter.
- Over five years, Shares Issued peaked at $52.7 million in Q1 2021 and troughed at -$619238.0 in Q2 2023.
- A 5-year average of $5.2 million and a median of $63573.0 in 2022 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2024: Shares Issued plunged 1074.06% in 2023, then surged 1500.2% in 2024.
- A 5-year view of Shares Issued shows it stood at -$103830.0 in 2021, then surged by 233.45% to $138557.0 in 2022, then jumped by 570.7% to $929298.0 in 2023, then surged by 1500.2% to $14.9 million in 2024, then plunged by 33.67% to $9.9 million in 2025.
- Business Quant data shows MRKR's Shares Issued at $9.9 million in Q4 2025, $100.0 in Q2 2025, and $505.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 26,927.15 |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.86 Mn |
| Dec 31, 2025 | 9.86 Mn |
| Jun 30, 2025 | 100.00 |
| Jun 30, 2025 | 100.00 |
| Mar 31, 2025 | 505.00 |
| Mar 31, 2025 | 505.00 |
| Dec 31, 2024 | 14.87 Mn |
| Dec 31, 2024 | 14.87 Mn |
| Sep 30, 2024 | 1,701.00 |
| Sep 30, 2024 | 1,701.00 |
| Jun 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 40,000.00 |
| Mar 31, 2024 | 49,096.00 |
| Mar 31, 2024 | 49,096.00 |
| Dec 31, 2023 | 929,298.00 |
| Dec 31, 2023 | 929,298.00 |
| Sep 30, 2023 | 84,606.00 |
| Sep 30, 2023 | 84,606.00 |
| Jun 30, 2023 | -619,238.00 |
| Jun 30, 2023 | -619,238.00 |